The progressive supranuclear palsy (PSP) therapies..

Criou um novo artigo

2 anos - Traduzir

The progressive supranuclear palsy (PSP) therapies market, is anticipated to grow at an annualized rate of over 35% | #progressive supranuclear palsy # progressive supranuclear palsy treatment market # progressive supranuclear palsy market # progressive supranuclear palsy market size

The progressive supranuclear palsy (PSP) therapies market, is anticipated to grow at an annualized rate of over 35%

The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy.